Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamy Ard

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Diabetes Care|December 3, 2025
The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 DiabetesLeah M Schumacher, Sarah Bauerle Bass, Jamy Ard, et al.
Diabetes Care|May 20, 2026
Response to Comment on Schumacher et al. Addressing the Feasibility Gap in Shared Decision-Making for Obesity and Type 2 Diabetes CareLeah M Schumacher, Sarah Bauerle Bass, Jamy Ard, et al.
Obesity Science & Practice|July 2, 2025
Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE StudyJamy Ard, Julia P Dunn, Hong Kan, et al.
Clinical Trials (London, England)|October 2, 2008
Design considerations and rationale of a multi-center trial to sustain weight loss: the Weight Loss Maintenance TrialPhillip Brantley, Lawrence Appel, Jack Hollis, et al.
Current Developments in Nutrition|February 3, 2025
Perspective: Current Scientific Evidence and Research Strategies in the Role of Almonds in Cardiometabolic HealthPaula R Trumbo, Jamy Ard, France Bellisle, et al.
Obesity (Silver Spring, Md.)|July 3, 2019
Response to "Knowledge Gaps in Long-Term Phentermine Use"Kristina H Lewis, Heidi Fischer, Jamy Ard, et al.
Nature Medicine|February 27, 2024
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Nature Medicine|October 15, 2023
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Annals of Epidemiology|December 3, 2014
Longitudinal association of anthropometric measures of adiposity with cardiometabolic risk factors in postmenopausal womenGeoffrey C Kabat, Moonseong Heo, Linda V Van Horn, et al.
Population Health Management|April 2, 2025
Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE StudyJamy Ard, Lee M Kaplan, Scott Kahan, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Diabetes Care|December 3, 2025
The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 DiabetesLeah M Schumacher, Sarah Bauerle Bass, Jamy Ard, et al.
Diabetes Care|May 20, 2026
Response to Comment on Schumacher et al. Addressing the Feasibility Gap in Shared Decision-Making for Obesity and Type 2 Diabetes CareLeah M Schumacher, Sarah Bauerle Bass, Jamy Ard, et al.
Obesity Science & Practice|July 2, 2025
Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE StudyJamy Ard, Julia P Dunn, Hong Kan, et al.
Clinical Trials (London, England)|October 2, 2008
Design considerations and rationale of a multi-center trial to sustain weight loss: the Weight Loss Maintenance TrialPhillip Brantley, Lawrence Appel, Jack Hollis, et al.
Current Developments in Nutrition|February 3, 2025
Perspective: Current Scientific Evidence and Research Strategies in the Role of Almonds in Cardiometabolic HealthPaula R Trumbo, Jamy Ard, France Bellisle, et al.
Obesity (Silver Spring, Md.)|July 3, 2019
Response to "Knowledge Gaps in Long-Term Phentermine Use"Kristina H Lewis, Heidi Fischer, Jamy Ard, et al.
Nature Medicine|February 27, 2024
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Nature Medicine|October 15, 2023
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Annals of Epidemiology|December 3, 2014
Longitudinal association of anthropometric measures of adiposity with cardiometabolic risk factors in postmenopausal womenGeoffrey C Kabat, Moonseong Heo, Linda V Van Horn, et al.
Population Health Management|April 2, 2025
Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE StudyJamy Ard, Lee M Kaplan, Scott Kahan, et al.
Pageof 6